Navigation Links
Winner Medical Enters into Definitive Merger Agreement with Winner Holding Limited
Date:7/24/2012

ing day prior to the Company's announcement of its receipt of a "going-private" proposal.

Parent has a secured debt facility from DBS Bank Ltd., Hong Kong Branch, with which it is financing the transactions contemplated by the Merger Agreement.

The Company's Board of Directors, acting upon the unanimous recommendation of a special committee of the Board of Directors comprised solely of independent and disinterested directors (the "Special Committee"), approved and adopted the Merger Agreement and has recommended that the Company's stockholders vote to approve the Merger Agreement.  The Special Committee negotiated the terms of the Merger Agreement with the assistance of its financial and legal advisors.

The transaction, which is currently expected to close before the end of the first fiscal quarter of 2013, is subject to the approval of the Merger Agreement by an affirmative vote of stockholders of both (i) a majority of the outstanding shares of the Company's common stock and (ii) a majority of the outstanding shares of the Company's common stock not owned by Parent, Merger Sub, Mr. Jianquan Li or Ms. Ping Tse, voting in person or by proxy at a special meeting of stockholders of the Company. 

The Company will call a special meeting of its stockholders for the purpose of voting on the adoption of the Merger Agreement. If completed, the transaction will result in the Company becoming a privately held company and its shares will no longer be listed on The NASDAQ Global Market.

William Blair & Company, L.L.C. is serving as financial advisor to the Special Committee. Cleary Gottlieb Steen & Hamilton LLP is serving as U.S. legal advisor to the Special Committee. Winston & Strawn LLP is serving as U.S. legal advisor to the Company. Skadden, Arps, Slate, Meagher & Flom LLP is serving as U.S. legal advisor to Mr. Jianquan Li. McDermott Will & Emery LLP is serving as U.S. legal advisor to William Blair & C
'/>"/>

SOURCE Winner Medical Group Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Telemedicine, Teleradiology, and Telemonitoring Look Like Winners in the New Healthcare Economy
2. Data Intelligence Limited Recognized as Winner of 2012 Microsoft Life Sciences Innovation Awards
3. Lilly Diabetes Announces Once Upon A Time Contest Winner
4. Sterne, Kessler, Goldstein & Fox Selected by 15 Year Old Winner of Intel International Science and Engineering Fair
5. UBM Canon and MD+DI Proudly Announce 25 Innovative Products as Winners of the 2012 Medical Design Excellence Awards
6. StreamVenue Healthcare CEO Named Peoples Choice Winner
7. Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT
8. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
9. No Medical Degree Necessary: An Easy Guide to Understanding Your Probiotic Supplement Label
10. TeNS Medical Services: Blogging for a Pain Free Future
11. Frost & Sullivan Recognizes Secant Medical as a Key Technology Enabler for Medical Implantable Textile Structures Design
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Lpath, Inc. (NASDAQ: LPTN ... reported interim results in a Phase 2a single-arm, ... a treatment for metastatic renal cell carcinoma (RCC) ... therapy involving a VEGF inhibitor (e.g., Sutent®/ sunitinib ... (e.g., Afinitor®/everolimus), with a maximum of three failed ...
(Date:7/24/2014)... 2014  Market Diagnostics International LLC ("MDxI") today ... , a data resource that sets a new ... and identifying target In Vitro Diagnostics (IVD) customers. ... provides IVD manufacturers with accurate and comprehensive information ... and consistent definitions of laboratory categories and institutional ...
(Date:7/24/2014)... , July 24, 2014   Cypher ... today a co-promotion agreement with Illumina to facilitate ... sequence data for precision medicine and clinical trials. ... companies, through Illumina,s sales force, a solution including ... for data analytics and storage, and Cypher Genomics, ...
Breaking Medicine Technology:Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 3Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 4MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 3
... IRVINE, Calif., June 12 Masimo (Nasdaq: ... Motion and Low-Perfusion pulse oximetry, announced today that three ... of Masimo PVI as a noninvasive and continuous measure ... week at the European Society of Anaesthesiology (ESA) Annual ...
... Safety and Biologic Activity Data Reviewed in End of Phase ... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... treatment of cardiovascular and metabolic disease, announced today that an ... VIA-2291 (atreleuton), was recently held with the U.S. Food and ...
Cached Medicine Technology:New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 6VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 5
(Date:7/24/2014)... Mass. (PRWEB) July 24, 2014 Dr. ... Beth Israel Deaconess Medical Center in Boston, is the ... . Dr. Oettgen brings his considerable experience in the ... EBSCO Health . , Dr. Oettgen received his ... Medicine and completed his residency at Tufts New England ...
(Date:7/24/2014)... July 24, 2014 The first-ever successful ... a patient’s blood has been achieved by NFCR-supported scientist ... General Hospital. This is an important milestone on the ... selecting the best treatment for each patient. , ... “They often acquire new genetic features that make them ...
(Date:7/24/2014)... LSE Health and the European Heart Academy (EHA) ... pleased to announce the launch of a new, ... field of cardiovascular sciences. , The MSc in ... aims to equip cardiovascular specialists with the health ... take on advisory, management or leadership roles within ...
(Date:7/24/2014)... Texas at Arlington professor who co-authored a book ... in community revitalization has been awarded the Community ... Martinez-Cosio, associate professor in the School of Urban ... week at the society,s national conference, along with ... academic coordinator in the Urban Studies and Planning ...
(Date:7/24/2014)... seldom sufficient to read the declaration of contents if you ... fact, to do this you need to be a highly ... you can look directly into the molecular structure of the ... Engineering, is almost both, as he has developed a method ... biological samples. , The ,Fingerprints, of a Substance ...
Breaking Medicine News(10 mins):Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 2Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 3Health News:New Blood Test Advances Individualized Cancer Therapy and Cuts Down on Need for Painful Biopsies 2Health News:LSE and ESC announce the launch of a new executive-style MSc 2Health News:Strategy for community development partnerships earns award for UT Arlington professor 2Health News:Chemist develops X-ray vision for quality assurance 2Health News:Chemist develops X-ray vision for quality assurance 3
... of Emerging Models of Care , , ... The Case Management Society of America ( CMSA ) will host ... the Grand Hyatt San Antonio in San Antonio, Texas . ... Association of Social Workers, DMAA: The Care Continuum Alliance, and The ...
... retail opportunities for fresh roasted fortified coffee. , ... ... first in caffeine and fat burning fresh roasted coffee products, has ... partnership in the coffee industry will push the JavaFit brand ...
... Individuals reporting a history of periodontal disease were ... a risk factor for heart disease, compared to ... according to an American Journal of Cardiology ... from Columbia University Medical Center and NewYork-Presbyterian Hospital, ...
... L. Chao today announced the appointment of five members to ... (NACOSH). The committee, established under the Occupational Safety and ... health and human services on occupational safety and health programs. ... the advisory committee members, willingness to contribute their time and ...
... The Lose For Good(TM) Campaign Reaches $1 Million Dollar Donation ... Banks in Need , , ... WTW ) is pleased to announce the donation of one ... Strength and Action Against Hunger. The donation was made ...
... Inc. (Nasdaq: ALXN ) today announced that Dr. ... at the 20th Annual Piper Jaffray Health Care Conference in ... 2, 2008. , , An ... You can access the webcast at: www.alexionpharm.com . An ...
Cached Medicine News:Health News:2009 Collaborative Practice Summit to Bring Together Health Care Leaders 2Health News:2009 Collaborative Practice Summit to Bring Together Health Care Leaders 3Health News:JavaFit, Distributors of Vitamin Infused Fresh Roasted Coffee, Announces Partnership With CLR Roasters 2Health News:Presence of gum disease may help dentists and physicians identify risk for cardiovascular disease 2Health News:Presence of gum disease may help dentists and physicians identify risk for cardiovascular disease 3Health News:U.S. Labor Secretary Elaine L. Chao announces new membership of OSHA advisory committee 2Health News:U.S. Labor Secretary Elaine L. Chao announces new membership of OSHA advisory committee 3Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 3Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: